Displaying 1–10 of 16 news results
Apr 22, 2022
The Foundation’s Investing in Cures Summit (ICS), held on April 2, 2022, in Half Moon Bay, California, convened 175 researchers, industry executives, and constituents to present and discuss the expanding and accelerating commercial development of emerging therapies for retinal degenerative diseases.
Jul 20, 2021
The Foundation believes that all people with disabilities should receive the accommodations necessary for their inclusion in all facets of society, especially when an individual may be unfamiliar with the area.
Oct 6, 2020
May 7, 2020
Delays in Research Impacting Therapy Development
Mar 31, 2020
The Foundation Fighting Blindness is closely monitoring the COVID-19 situation and its impact on the IRD community.
Feb 3, 2020
Please note that the seventh annual Retinal Cell and Gene Therapy Innovation Summit previously scheduled for Friday, May 1st, 2020 in Baltimore, Maryland has been cancelled.
Jan 29, 2020
The Foundation Fighting Blindness VISIONS 2020 conference will be held on June 18-20th at the Hyatt Regency Minneapolis.
Aug 16, 2019
The newly funded research efforts include several therapies that have strong potential to treat a wide range of inherited retinal diseases.
Jun 3, 2019
A discussion of strategies concerning the development of autosomal dominant disease therapies at the Translational Research Acceleration Program (TRAP) in November 2013.
Mar 7, 2019
Age-related macular degeneration (AMD) is the leading cause of blindness for people over 50 years of age in developed countries.